JP Morgan Chase
ASBPW

JP Morgan Chase’s Aspire Biopharma Warrant ASBPW Stock Holding History

JP Morgan Chase’s Portfolio ASBPW Stock Details ASBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Hold
0
– – – 7075
2025
Q4 		– Hold
0
– – – 6974
2025
Q3 		– Hold
0
– – – 6850
2025
Q2 		– Hold
0
– – – 6430
2025
Q1 		– Hold
0
– – – 6386
2024
Q4 		– Hold
0
– – – 6525
2024
Q3 		– Hold
0
– – – 6522
2024
Q2 		– Hold
0
– – – 6464
2024
Q1 		– Hold
0
– – – 6526
2023
Q4 		– Hold
0
– – – 6526

Other funds holding ASBPW

MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return